Congratulations! You have an all-male executive team
This article was originally published in Scrip
Executive Summary
It's 2015, and nine of the top 39 pharmaceutical companies in Europe and North America have no women within their senior executive team. Eight of those nine companies are headquartered in supposedly egalitarian nations such as Switzerland, Germany, Denmark, and France. Fewer than 16% of the senior executives in these leading pharma firms are women. This article considers how likely it is that this situation arose by chance.
You may also be interested in...
Glass Ceiling Cracked; Pharma Forges Path To Gender Equality By 2040?
One woman CEO is an improvement, but at this rate gender equality won't arrive before immuno-oncology goes generic.
Gender Diversity In Pharma: Caught Between Desire And Reality
Charting the executive gender mix across 384 companies from mid-2014 to mid-2019 demonstrates that C-suite gender balance in pharma is moving towards a point that more closely reflects its total workforce, but that progress has been slow and that there is a long road to travel before the transformation is complete.
Women In High Places: Slow Progress In Pharma
With gender diversity only slowly increasing in biopharma c-suites, Scrip spoke to executives from five companies about the importance of change.